サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1526170

経鼻ドラッグデリバリーの世界市場

Intranasal Drug Delivery
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 459 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.16円
経鼻ドラッグデリバリーの世界市場
出版日: 2024年08月05日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 459 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

経鼻ドラッグデリバリーの世界市場は2030年までに926億米ドルに到達

2023年に591億米ドルと推定された経鼻ドラッグデリバリーの世界市場は、分析期間2023-2030年にCAGR 6.6%で成長し、2030年には926億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである液体送達デバイスは、CAGR 6.2%を記録し、分析期間終了時には380億米ドルに達すると予測されます。粉末投与装置セグメントは、分析期間中にCAGR 7.5%の成長が見込まれます。

米国市場は246億米ドル、中国はCAGR 8.9％で成長予測

米国の経鼻ドラッグデリバリー市場は2023年に246億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに81億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは8.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.3％と5.4％と予測されています。欧州では、ドイツがCAGR約6.4%で成長すると予測されています。

世界の経鼻ドラッグデリバリー市場- 主要動向と促進要因のまとめ

経鼻ドラッグデリバリーとは、鼻腔から薬剤を投与することを指し、非侵襲的かつ効率的な薬物吸収経路を提供します。この方法は、鼻粘膜の豊富な血管と広い表面積を活用し、他の非侵襲的経路と比較して迅速な作用発現と生物学的利用能の向上を可能にします。経鼻デリバリーシステムは、疼痛管理、神経疾患、予防接種など、さまざまな薬物に利用されています。これらのシステムを支える技術には、定量点鼻スプレー、点鼻ジェル、粉末製剤などがあり、それぞれ薬物の吸収を最適化し、全身的な副作用を最小限に抑えるように設計されています。

経鼻ドラッグデリバリーの用途はいくつかの治療分野にまたがり、現代医療における汎用性の高いツールとなっています。特に、オピオイドの過剰摂取に対するナロキソンやアナフィラキシー反応に対するエピネフリンなど、迅速な薬物作用が重要な緊急事態において有益です。さらに、経鼻投与は、片頭痛やホルモン療法のような慢性疾患で、注射に代わる便利で非侵襲的な方法として、ますます使用されるようになっています。消化管を迂回し、肝臓で初回通過代謝を受けることができるため、経口では吸収が悪かったり、代謝が進んだりする薬物にも有利です。

経鼻ドラッグデリバリー市場の成長は、送達技術の進歩、迅速な介入を必要とする慢性・急性疾患の増加、患者やヘルスケア提供者の非侵襲的投与方法への嗜好の高まりなど、いくつかの要因によってもたらされます。製剤の改良や新しいデリバリー・デバイスなどの技術革新は、薬物の安定性と吸収性を高め、治療可能な病態の幅を広げています。さらに、人口の高齢化やアルツハイマー病やパーキンソン病などの疾患の増加といった人口動態の動向も、より効果的なドラッグデリバリーシステムに対する需要を高めています。自己投与や在宅ケアへの消費者行動のシフトは、ヘルスケアコスト抑制戦略と相まって、市場拡大をさらに後押しします。特にCOVID-19のパンデミックによって脚光を浴びた経鼻ワクチンの開発も、世界の保健戦略におけるこの送達方法の重要な役割を強調しています。

調査対象企業の例（注目の77社）

  • Acorda Therapeutics, Inc.
  • Ferring Pharmaceuticals Inc
  • Bespak Europe Ltd.
  • Breckenridge Pharmaceutical, Inc.
  • Janssen Global Services LLC
  • Hikma Pharmaceuticals PLC
  • Biologische Heilmittel Heel GmbH
  • Evoke Pharma, Inc.
  • KemPharm, Inc.
  • Impel NeuroPharma
  • Actiza Pharmaceutical Pvt., Ltd.
  • Covis Pharma
  • H&T Presspart Manufacturing Ltd.
  • Biomedica International
  • Alchemy Pharmatech Ltd.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-1795

Global Intranasal Drug Delivery Market to Reach US$92.6 Billion by 2030

The global market for Intranasal Drug Delivery estimated at US$59.1 Billion in the year 2023, is expected to reach US$92.6 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. Liquid Delivery Devices, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$38.0 Billion by the end of the analysis period. Growth in the Powder Delivery Devices segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$24.6 Billion While China is Forecast to Grow at 8.9% CAGR

The Intranasal Drug Delivery market in the U.S. is estimated at US$24.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$8.1 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.3% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Intranasal Drug Delivery Market - Key Trends and Drivers Summarized

Intranasal drug delivery refers to the administration of medications through the nasal cavity, offering a non-invasive and efficient route for drug absorption. This method leverages the rich vascularization and large surface area of the nasal mucosa, enabling rapid onset of action and enhanced bioavailability compared to other non-invasive routes. Intranasal delivery systems are utilized for a variety of drugs, including those for pain management, neurological disorders, and vaccinations. The technology behind these systems includes metered-dose nasal sprays, nasal gels, and powder formulations, each designed to optimize drug absorption and minimize systemic side effects.

The application of intranasal drug delivery spans several therapeutic areas, making it a versatile tool in modern medicine. It is particularly beneficial in emergency situations where rapid drug action is critical, such as with naloxone for opioid overdoses or epinephrine for anaphylactic reactions. Additionally, intranasal delivery is increasingly used for chronic conditions like migraines and hormonal therapies, where it offers a convenient and non-invasive alternative to injections. The ability to bypass the gastrointestinal tract and first-pass metabolism in the liver also makes this route advantageous for drugs that are poorly absorbed orally or extensively metabolized.

The growth in the intranasal drug delivery market is driven by several factors, including advancements in delivery technologies, increasing prevalence of chronic and acute conditions requiring rapid intervention, and a growing preference for non-invasive administration methods among patients and healthcare providers. Technological innovations, such as improved formulations and novel delivery devices, enhance drug stability and absorption, expanding the range of treatable conditions. Additionally, demographic trends such as aging populations and rising incidences of conditions like Alzheimer's disease and Parkinson's disease fuel demand for more effective drug delivery systems. Consumer behavior shifts towards self-administration and home care, coupled with healthcare cost containment strategies, further propel market expansion. The development of intranasal vaccines, particularly highlighted by the COVID-19 pandemic, also underscores the critical role of this delivery method in global health strategies.

Select Competitors (Total 77 Featured) -

  • Acorda Therapeutics, Inc.
  • Ferring Pharmaceuticals Inc
  • Bespak Europe Ltd.
  • Breckenridge Pharmaceutical, Inc.
  • Janssen Global Services LLC
  • Hikma Pharmaceuticals PLC
  • Biologische Heilmittel Heel GmbH
  • Evoke Pharma, Inc.
  • KemPharm, Inc.
  • Impel NeuroPharma
  • Actiza Pharmaceutical Pvt., Ltd.
  • Covis Pharma
  • H&T Presspart Manufacturing Ltd.
  • Biomedica International
  • Alchemy Pharmatech Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Intranasal Drug Delivery - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Intranasal Drug Delivery: A Prelude
    • Leading Indications and APIs Amenable to Nasal Drug Delivery
    • Regional Market Analysis
    • Why Nasal Application is Garnering Notable Attention for Drug Delivery
    • Limitations of Intranasal Drug Delivery
    • Overview of the Traditional Drug Administration Routes, Molecular Weight Capabilities, and Dosage Range
    • Drug Delivery Pathways Related to the Nasal Cavity
    • Systemic delivery and Local Delivery Routes
    • Differences between Systemic Delivery and Local Effects
    • Challenges Involved In Formulating Nasal Drugs
    • Intranasal Cavity: An Attractive Drug Delivery Route to Cross the Blood Brain Barrier
    • Nose-to-Brain Drug Delivery: An Evolving Area of Interest
    • Factors Inhibiting Nose-to-Brain Transportation of Drugs
    • Bioavailability: An Important Facet of Intranasal Drug Delivery
    • Traditional Vs. Advanced Intranasal Drug Formulation Types
    • Type of Nasal Delivery Vehicles with Select Therapeutic Agents and Area of Application
    • Select FDA-Approved Nasal Products Compound (Trade Name) Indication Dosage Form Year
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Prevalence of COPD Drives Opportunities
    • Global Prevalence of COPD: Percentage of Men and Women Affected by Age Group
    • Pharmaceutical and Medical Device Companies Vie to Develop New Intranasal Therapeutics for Allergic Rhinitis Patients
    • Prevalence Percentage of COPD, Asthma, and Allergic Rhinitis for Select Countries
    • The US - FDA Approved Intranasal Corticosteroids (INAC) and Intranasal Antihistamines (INAH) for Treating Allergic Rhinitis
    • The US - FDA Approved Nasal Spray Medication Types (excluding INAC & INAH) for Allergic Rhinitis Treatment
    • Intranasal Corticosteroids : A Potential Treatment for Debilitating Chronic Rhinosinusitis Disease
    • Select Intranasal Corticosteroid Brands for Adult and Pediatric Usage
    • Manufacturers Focus on Improved Nasal Delivery Platforms
    • Controlled Release Technology is the Buzz Word
    • Research on Nanocarrier-Based Intranasal Drug Delivery Systems Picks Up Pace
    • Potential Role in Treatment and Management of Coronavirus Infection
    • Self-Administration of Drugs Brings Intranasal Drug Delivery into the Spotlight
    • Nasal Drug Delivery Offers New Opportunities for Drug Developers as Patent Cliffs Usher in Dusk of Blockbuster Era
    • Active Pharmaceutical Ingredients Used in Formulations for Nasal Drug Delivery with Related Indications
    • Increasing R&D Unlocks New Therapeutic Areas for Nasal Drug Delivery
    • Intranasal Therapeutics Delivery: A High Potential Method for Treating CNS Diseases
    • Researchers Develop Nasal Spray Treatment for Parkinson's Disease
    • Future Opportunities in CNS Space
    • Intranasal Delivery of Stem Cells: A Primary Strategy for Treatment of CNS Disorders
    • Intranasal Delivery of Stem Cells: Limitations
    • Diagnosed Prevalence Cases of Parkinson's Disease Across Select Countries
    • Intranasal Delivery of Peptide-Based Pharmaceuticals
    • Select Protein, Peptide & Non-Peptide Drugs Available as Nasal Spray Solutions in the Marketplace
    • Select List of Nasal Biologics Available in the Market
    • Benefits of Bi-Directional Nasal Drug Delivery
    • Rise in Interest in Preservative-free Nasal Spray Formulations
    • Burgeoning Geriatric Populace Spurs Growing Demand for Intranasal Drug Therapies
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Liquid Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Liquid Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 3: World 14-Year Perspective for Liquid Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Powder Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Powder Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 6: World 14-Year Perspective for Powder Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Pressurized Metered Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Pressurized Metered Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 9: World 14-Year Perspective for Pressurized Metered Dose Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 12: World 14-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Respiratory Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Respiratory Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 15: World 14-Year Perspective for Respiratory Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Neurological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 18: World 14-Year Perspective for Neurological Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 21: World 14-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 24: World 14-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2016, 2024 & 2030
    • TABLE 25: World Intranasal Drug Delivery Market Analysis of Annual Sales in US$ Million for Years 2016 through 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Intranasal Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 28: World 14-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2016, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 31: USA 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 34: USA 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 37: Canada 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 40: Canada 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • JAPAN
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 43: Japan 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 46: Japan 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • CHINA
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 49: China 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 52: China 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • EUROPE
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 55: Europe 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 58: Europe 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Intranasal Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 61: Europe 14-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2016, 2024 & 2030
  • FRANCE
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 64: France 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 67: France 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • GERMANY
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 70: Germany 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 73: Germany 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 76: Italy 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 79: Italy 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • UNITED KINGDOM
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 82: UK 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 85: UK 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 88: Spain 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 91: Spain 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 94: Russia 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 97: Russia 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • ASIA-PACIFIC
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Intranasal Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 14-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2016, 2024 & 2030
  • AUSTRALIA
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 115: Australia 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 118: Australia 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • INDIA
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 121: India 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 124: India 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 127: South Korea 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 130: South Korea 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • LATIN AMERICA
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 139: Latin America 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 142: Latin America 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Intranasal Drug Delivery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 145: Latin America 14-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2016, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 148: Argentina 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 151: Argentina 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 154: Brazil 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 157: Brazil 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 160: Mexico 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 163: Mexico 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • MIDDLE EAST
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 172: Middle East 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 175: Middle East 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Intranasal Drug Delivery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 178: Middle East 14-Year Perspective for Intranasal Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2016, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 181: Iran 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 184: Iran 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 187: Israel 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 190: Israel 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 199: UAE 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 202: UAE 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030
  • AFRICA
    • Intranasal Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Intranasal Drug Delivery by Product Type - Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 211: Africa 14-Year Perspective for Intranasal Drug Delivery by Product Type - Percentage Breakdown of Value Sales for Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers and Other Product Types for the Years 2016, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Intranasal Drug Delivery by Application - Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2016 through 2022 and % CAGR
    • TABLE 214: Africa 14-Year Perspective for Intranasal Drug Delivery by Application - Percentage Breakdown of Value Sales for Respiratory Disorders, Neurological Disorders, Pain Management and Other Applications for the Years 2016, 2024 & 2030

IV. COMPETITION